Elite Wealth Management’s Gilead Sciences GILD Stock Holding History

Elite Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Buy	10,468 +359	+4%	+$50.3K	0.47%	25
2025 Q4	$1.24M	Buy	10,109 +300	+3%	+$36.5K	0.34%	30
2025 Q3	$1.09M	Buy	+9,809	New	+$1.11M	0.28%	31
2018 Q1	–	Sell	-3,379	Closed	-$242K	–	61
2017 Q4	$242K	Buy	+3,379	New	+$257K	0.2%	55
2016 Q3	$166K	Buy	+2,100	New	+$171K	0.27%	41
2015 Q4	–	Sell	-9,777	Closed	-$960K	–	52
2015 Q3	$960K	Sell	9,777 -8,897	-48%	-$988K	1.51%	20
2015 Q2	$2.19M	Buy	18,674 +5,699	+44%	+$623K	2.26%	8
2015 Q1	$1.27M	Buy	+12,975	New	+$1.32M	1.13%	32
2014 Q2	–	Sell	-100	Closed	-$7.78K	–	465
2014 Q1	$7K	Buy	+100	New	+$7.84K	0.01%	259

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Elite Wealth Management's GILD Position: Q1 2026 in Review

Elite Wealth Management increased its Gilead Sciences (GILD) stake by 3.6% in Q1 2026, buying an estimated $50.3K and bringing the position to 10,468 shares worth $1.46M. The position accounts for 0.47% of the portfolio, ranked #25.

Elite Wealth Management first reported a position in GILD in Q1 2014 and has held it in 9 quarters since. The position peaked at $2.19M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Elite Wealth Management held 10,468 shares of Gilead Sciences worth $1.46M as of Q1 2026.
Elite Wealth Management bought 359 Gilead Sciences shares in Q1 2026, an estimated $50.3K.
Gilead Sciences made up 0.47% of Elite Wealth Management's portfolio in Q1 2026, its #25 holding.
Elite Wealth Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 9 quarters since.
Elite Wealth Management's Gilead Sciences position peaked at $2.19M in Q2 2015.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Elite Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.